Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential CD146 and GPC3 CAR-T in Advanced Ovarian Cancer
NCT07067255Phase 2Recruiting
- Sponsor
- Essen BioTech
- Start
- Apr 2025
- Primary completion
- Dec 2028
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of AZD7003 in ovarian cancer, sponsored by Essen BioTech. Started Apr 2025; status: recruiting.
02
Drugs
AZD7003
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT07067255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07067255.